Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: HPB (Oxford). 2016 Dec 1;19(2):133–139. doi: 10.1016/j.hpb.2016.11.002

Table 3.

Pathologic or radiologic diagnoses for cases in which the treatment plan was changed after MDTB discussion.

Pathologic or Radiologic Diagnosis n %
Pancreatic adenocarcinoma 42 41.6%
Pancreatic mass 18 17.8%
Neuroendocrine tumor 9 8.9%
Pancreatitis 7 6.9%
Bile duct mass, stricture, obstruction, jaundice 5 5.0%
Pancreatic cyst 4 4.0%
Cholangiocarcinoma 4 4.0%
Ampullary cancer or mass 2 2.0%
Intraductal papillary mucinous neoplasm 3 3.0%
Gastric cancer or mass 2 2.0%
Other mass or malignancy 3 3.0%
Other benign condition 2 2.0%
    Total 101